MCID: PYR022
MIFTS: 49

Pyruvate Dehydrogenase E1-Alpha Deficiency malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Metabolic diseases, Fetal diseases

Aliases & Classifications for Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section
Sources:
11Disease Ontology, 12diseasecard, 13DISEASES, 24GeneTests, 25Genetics Home Reference, 27GTR, 30ICD10, 31ICD10 via Orphanet, 37MedGen, 39MeSH, 40MESH via Orphanet, 45NCIt, 48NIH Rare Diseases, 52OMIM, 54Orphanet, 62SNOMED-CT, 64The Human Phenotype Ontology, 68UMLS, 69UMLS via Orphanet, 70UniProtKB/Swiss-Prot
See all MalaCards sources

Aliases & Descriptions for Pyruvate Dehydrogenase E1-Alpha Deficiency:

Name: Pyruvate Dehydrogenase E1-Alpha Deficiency 52 24 54 70 27 12
Pyruvate Dehydrogenase Complex Deficiency 48 24 25 54 27
Pyruvate Dehydrogenase Deficiency 11 48 25 54 70
Pyruvate Decarboxylase Deficiency 11 48 54 70 13
Pyruvate Dehydrogenase Complex Deficiency Disease 11 39 68
Pdh Deficiency 24 25 70
Pdhc Deficiency 24 25
Pdhad 54 70
Pdhc 48 54
Ataxia, Intermittent, with Pyruvate Dehydrogenase, or Decarboxylase, Deficiency 48
Ataxia Intermittent with Pyruvate Dehydrogenase or Decarboxylase Deficiency 70
 
Pyruvate Dehydrogenase Complex E1 Component Subunit Alpha Deficiency 54
Intermittent Ataxia with Pyruvate Dehydrogenase Deficiency 25
Ataxia Intermittent with Abnormal Pyruvate Metabolism 70
Pyruvate Dehydrogenase E1 Alpha Deficiency 68
Pyruvate Dehydrogenase E1 a Deficiency 24
Deficiency of Pyruvic Dehydrogenase 11
Ataxia with Lactic Acidosis 1 48
Ataxia with Lactic Acidosis I 70
Ataxia with Lactic Acidosis 25
Pdh 54

Characteristics:

Orphanet epidemiological data:

54
pyruvate dehydrogenase complex deficiency:
Inheritance: Autosomal recessive,Not applicable,X-linked dominant; Prevalence: <1/1000000 (Europe); Age of onset: Childhood,Infancy,Neonatal; Age of death: adolescent,late childhood
pyruvate dehydrogenase e1-alpha deficiency:
Inheritance: X-linked dominant; Age of onset: Infancy,Neonatal; Age of death: adolescent,late childhood

HPO:

64
pyruvate dehydrogenase e1-alpha deficiency:
Inheritance: x-linked dominant inheritance
Onset and clinical course: infantile onset, phenotypic variability

Classifications:



External Ids:

OMIM52 312170
Disease Ontology11 DOID:3649
ICD1030 E74.4, R27.0
MeSH39 D015325
NCIt45 C103968
MESH via Orphanet40 C536257, D015325
UMLS via Orphanet69 C0034345, C2936911
ICD10 via Orphanet31 E74.4

Summaries for Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section
NIH Rare Diseases:48 Pyruvate dehydrogenase deficiency is metabolic disorder associated with abnormal function of the mitochondria in cells, thus depriving the body of energy. Progressive neurological symptoms usually start in infancy but may be evident at birth, or in later childhood; these symptoms may include developmental delay, intermittent ataxia, poor muscle tone (hypotonia), abnormal eye movements, or seizures. Severe lethargy, poor feeding, and tachypnea (rapid breathing) commonly occur, especially during times of illness, stress, or high carbohydrate intake. Childhood-onset forms of the condition are often associated with intermittent periods of illness but normal neurological development. Prognosis is difficult to predict due to the many causes of the condition, but in most cases of neonatal and infantile onset, prognosis is described as poor. The most common form of pyruvate dehydrogenase deficiency is caused by mutations in the E1 alpha gene, and is inherited in an X-linked dominant manner; all other forms are caused by various genes and are inherited in an autosomal recessive manner. In addition to directly treating acidosis and providing alternative energy for the body, treatment typically includes dietary supplementation with thiamine, carnitine, and lipoic acids, although not all individuals respond to this therapy. Last updated: 1/4/2011

MalaCards based summary: Pyruvate Dehydrogenase E1-Alpha Deficiency, also known as pyruvate dehydrogenase complex deficiency, is related to pyruvate carboxylase deficiency and pyruvate dehydrogenase e1-beta deficiency, and has symptoms including muscular hypotonia, reduced consciousness/confusion and feeding difficulties in infancy. An important gene associated with Pyruvate Dehydrogenase E1-Alpha Deficiency is PDHA1 (Pyruvate Dehydrogenase (Lipoamide) Alpha 1), and among its related pathways are HIF-1 signaling pathway and Central carbon metabolism in cancer. Affiliated tissues include cortex, brain and eye, and related mouse phenotype Decreased shRNA abundance (Z-score < -2).

Disease Ontology:11 A carbohydrate metabolic disorder characterized by the buildup of lactic acid in the body and a variety of neurological problems and caused by a deficiency of one of the three enzymes in the pyruvate dehydrogenase complex.

Genetics Home Reference:25 Pyruvate dehydrogenase deficiency is characterized by the buildup of a chemical called lactic acid in the body and a variety of neurological problems. Signs and symptoms of this condition usually first appear shortly after birth, and they can vary widely among affected individuals. The most common feature is a potentially life-threatening buildup of lactic acid (lactic acidosis), which can cause nausea, vomiting, severe breathing problems, and an abnormal heartbeat. People with pyruvate dehydrogenase deficiency usually have neurological problems as well. Most have delayed development of mental abilities and motor skills such as sitting and walking. Other neurological problems can include intellectual disability, seizures, weak muscle tone (hypotonia), poor coordination, and difficulty walking. Some affected individuals have abnormal brain structures, such as underdevelopment of the tissue connecting the left and right halves of the brain (corpus callosum), wasting away (atrophy) of the exterior part of the brain known as the cerebral cortex, or patches of damaged tissue (lesions) on some parts of the brain. Because of the severe health effects, many individuals with pyruvate dehydrogenase deficiency do not survive past childhood, although some may live into adolescence or adulthood.

OMIM:52 Genetic defects in the pyruvate dehydrogenase complex are one of the most common causes of primary lactic acidosis in... (312170) more...

UniProtKB/Swiss-Prot:70 Pyruvate dehydrogenase E1-alpha deficiency: An enzymatic defect causing primary lactic acidosis in children. It is associated with a broad clinical spectrum ranging from fatal lactic acidosis in the newborn to chronic neurologic dysfunction with structural abnormalities in the central nervous system without systemic acidosis.

Related Diseases for Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section

Diseases related to Pyruvate Dehydrogenase E1-Alpha Deficiency via text searches within MalaCards or GeneCards Suite gene sharing:

idRelated DiseaseScoreTop Affiliating Genes
1pyruvate carboxylase deficiency11.4
2pyruvate dehydrogenase e1-beta deficiency11.1
3pyruvate dehydrogenase e2 deficiency11.0
4lactic acidosis10.1
5hyperammonemia9.8
6ataxia9.8
7leigh syndrome9.4PDHA1, PDHB, PDHX
8wheat allergy9.1PC, PDHA1, PDHX
9glycogen storage disease, type ixa18.1HIBCH, PC, PDHA1, PDHB, PDHX

Graphical network of diseases related to Pyruvate Dehydrogenase E1-Alpha Deficiency:



Diseases related to pyruvate dehydrogenase e1-alpha deficiency

Symptoms & Phenotypes for Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section

Symptoms by clinical synopsis from OMIM:

312170

Clinical features from OMIM:

312170

Human phenotypes related to Pyruvate Dehydrogenase E1-Alpha Deficiency:

 64 54 (show all 61)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 muscular hypotonia64 54 hallmark (90%) Very frequent (99-80%) HP:0001252
2 reduced consciousness/confusion64 hallmark (90%) HP:0004372
3 feeding difficulties in infancy64 54 hallmark (90%) Very frequent (99-80%) HP:0008872
4 microcephaly64 54 typical (50%) Frequent (79-30%) HP:0000252
5 abnormality of eye movement64 54 typical (50%) Frequent (79-30%) HP:0000496
6 seizures64 54 typical (50%) Frequent (79-30%) HP:0001250
7 hypertonia64 typical (50%) HP:0001276
8 gait disturbance64 54 typical (50%) Frequent (79-30%) HP:0001288
9 tremor64 54 typical (50%) Frequent (79-30%) HP:0001337
10 intrauterine growth retardation64 54 typical (50%) Frequent (79-30%) HP:0001511
11 chorea64 typical (50%) HP:0002072
12 neurological speech impairment64 typical (50%) HP:0002167
13 incoordination64 typical (50%) HP:0002311
14 abnormal pattern of respiration64 typical (50%) HP:0002793
15 abnormal pyramidal signs64 54 typical (50%) Frequent (79-30%) HP:0007256
16 aplasia/hypoplasia of the corpus callosum64 54 typical (50%) Frequent (79-30%) HP:0007370
17 cognitive impairment64 typical (50%) HP:0100543
18 abnormal facial shape64 54 35% Very frequent (99-80%) HP:0001999
19 abnormality of the palate64 occasional (7.5%) HP:0000174
20 trigonocephaly64 54 occasional (7.5%) Occasional (29-5%) HP:0000243
21 narrow face64 54 occasional (7.5%) Occasional (29-5%) HP:0000275
22 epicanthus64 54 occasional (7.5%) Occasional (29-5%) HP:0000286
23 hypertelorism64 54 occasional (7.5%) Occasional (29-5%) HP:0000316
24 long philtrum64 54 occasional (7.5%) Occasional (29-5%) HP:0000343
25 abnormality of the nose64 occasional (7.5%) HP:0000366
26 upslanted palpebral fissure64 54 occasional (7.5%) Occasional (29-5%) HP:0000582
27 pectus excavatum64 54 occasional (7.5%) Occasional (29-5%) HP:0000767
28 multiple lipomas64 54 occasional (7.5%) Occasional (29-5%) HP:0001012
29 frontal bossing64 54 occasional (7.5%) Occasional (29-5%) HP:0002007
30 respiratory insufficiency64 occasional (7.5%) HP:0002093
31 ventriculomegaly64 54 occasional (7.5%) Occasional (29-5%) HP:0002119
32 cerebral palsy64 54 occasional (7.5%) Occasional (29-5%) HP:0100021
33 wide nasal bridge64 54 Occasional (29-5%) HP:0000431
34 flared nostrils64 HP:0000454
35 anteverted nares64 HP:0000463
36 ptosis64 HP:0000508
37 intellectual disability64 HP:0001249
38 lethargy64 54 Very frequent (99-80%) HP:0001254
39 global developmental delay64 54 Frequent (79-30%) HP:0001263
40 choreoathetosis64 54 Frequent (79-30%) HP:0001266
41 agenesis of corpus callosum64 HP:0001274
42 dystonia64 54 Occasional (29-5%) HP:0001332
43 small for gestational age64 HP:0001518
44 cerebral atrophy64 HP:0002059
45 episodic ataxia64 HP:0002131
46 increased serum lactate64 HP:0002151
47 increased csf lactate64 HP:0002490
48 apneic episodes precipitated by illness, fatigue, stress64 HP:0002872
49 decreased activity of the pyruvate dehydrogenase complex64 HP:0002928
50 hyperalaninemia64 HP:0003348
51 severe lactic acidosis64 HP:0004900
52 chronic lactic acidosis64 HP:0004925
53 basal ganglia cysts64 HP:0006799
54 high palate54 Occasional (29-5%)
55 ataxia54 Frequent (79-30%)
56 spasticity54 Frequent (79-30%)
57 dysarthria54 Frequent (79-30%)
58 growth delay54 Very frequent (99-80%)
59 dyspnea54 Occasional (29-5%)
60 tachypnea54 Frequent (79-30%)
61 osteolytic defects of the middle phalanx of the 4th toe54 Frequent (79-30%)

UMLS symptoms related to Pyruvate Dehydrogenase E1-Alpha Deficiency:


lethargy, seizures, nasal flaring

GenomeRNAi Phenotypes related to Pyruvate Dehydrogenase E1-Alpha Deficiency according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00366-A-588.5HIBCH, PC, PDHB

Drugs & Therapeutics for Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section

Drugs for Pyruvate Dehydrogenase E1-Alpha Deficiency (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 9)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Pyruvateapproved, NutraceuticalPhase 338
2
Thiamineapproved, nutraceutical, vet_approved9859-43-81130
Synonyms:
100660-17-1
115461-66-0
1sbr
2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol
2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol chloride
3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydrox yethyl)-4-methylthiazolium chloride
3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m- ethylthiazolium chloride, monohydrochloride
3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride
3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride monohydrochloride
3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM
3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium
3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride hydrochloride
3[(4-Amino-2-methyl-5-pyrimidinyl)-methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride
55463-15-5
57777-32-9
59-43-8
67-03-8
AC-11683
AC1L1ASK
AC1L1LOC
AC1LAODT
AC1Q4V9Q
AI3-18993
AKOS000668650
AR-1L8201
Aneurin
Aneurine
Antiberiberi factor
Apatate drape
Apate drops
B-Amin
BAS 00266240
BPBio1_000686
BSPBio_000622
Beatine
Bedome
Begiolan
Beivon
Benerva
Bequin
Berin
Betabion
Betalin S
Betaxin
Bethiamin
Bethiazine
Beuion
Bevitex
Bevitine
Bewon
Biamine
Bithiamin
Biuno
Bivatin
Bivita
C00378
C12H17N4OS
CCRIS 1906
CCRIS 5823
CHEBI:18385
CHEBI:33283
CHEBI:49105
CHEMBL1547
CHEMBL1588
CID1130
CID517305
CID6042
Cernevit-12
Chloride-hydrochloride salt of thiamine
Clotiamina
D08580
DB00152
EINECS 200-425-3
EINECS 200-641-8
Eskapen
Eskaphen
FEMA No. 3322
 
HSDB 220
Hybee
I14-14339
LS-3226
LT00233141
Lixa-beta
MLS001304099
Metabolin
MolPort-000-722-048
MolPort-001-920-086
MolPort-002-052-059
NChemBio.2007.13-comp10
NSC 36226
NSC36226
Oryzanin
Oryzanine
Prestwick0_000631
Prestwick1_000631
Prestwick2_000631
Prestwick3_000631
SBB058094
SMP1_000084
SMR000718788
SPBio_002841
ST095175
Slowten
THD
THIAMIN, VITAMIN B1
Thiadoxine
Thiamin
Thiamin dichloride
Thiaminal
Thiamine
Thiamine (INN)
Thiamine HCL
Thiamine [INN:BAN]
Thiamine chloride
Thiamine chloride hydrochloride
Thiamine dichloride
Thiamine hydrochloride [JAN]
Thiamine monochloride
Thiamine monohydrochloride
Thiamine, chloride
Thiamine, chloride, hydrochloride
Thiamine, monohydrochloride
Thiaminium
Thiaminium chloride hydrochloride
Thiaminum
Thiaminum [INN-Latin]
Thiamol
Thiavit
Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m- ethyl, chloride, monohydrochloride
Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl- chloride
Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl- chloride (1:1)
Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, chloride, monohydrochloride
Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride
Tiamidon
Tiamina
Tiamina [INN-Spanish]
Tiaminal
TimTec1_000613
Trophite
UNII-X66NSO3N35
VIB
Vetalin S
Vinothiam
Vitamin B1
Vitamin B1 (TN)
Vitamin B1 hydrochloride (VAN)
Vitaneurin
Vitaneuron
ZINC00049153
[5-[[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]methyl]-2-methylpyrimidin-4-yl]azanium dichloride
bmse000274
nchembio.121-comp5
thiamin
thiamine
thiamine(1+)
thiamine(1+) ion
thiaminium
vitamin B1
vitamin b1(thiamine)
3Vitamins5095
4Lipid Regulating Agents2702
5Hypolipidemic Agents2721
6ACIPIMOX19
7Antimetabolites11774
8Pharmaceutical Solutions7793
9ThiaminNutraceutical98

Interventional clinical trials:

idNameStatusNCT IDPhase
1Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:Not yet recruitingNCT02616484Phase 3
2From Uncomplicated Alcoholism to Korsakoff's SyndromeUnknown statusNCT01455207
3Lipolytic Effects of GH in Hypopituitary Patients in VivoRecruitingNCT02782208
4Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy MetabolismAvailableNCT01461304
5A Pilot Study of Rapid Haplotyping Procedure for Personalized Dosing of Dichloroacetate (DCA) in Healthy VolunteersEnrolling by invitationNCT02690285

Search NIH Clinical Center for Pyruvate Dehydrogenase E1-Alpha Deficiency


Cochrane evidence based reviews: pyruvate dehydrogenase complex deficiency disease

Genetic Tests for Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section

Genetic tests related to Pyruvate Dehydrogenase E1-Alpha Deficiency:

id Genetic test Affiliating Genes
1 Pyruvate Dehydrogenase E1-Alpha Deficiency27 24 PDHA1
2 Pyruvate Dehydrogenase Complex Deficiency27 24

Anatomical Context for Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section

MalaCards organs/tissues related to Pyruvate Dehydrogenase E1-Alpha Deficiency:

36
Cortex, Brain, Eye

Publications for Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section

Variations for Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section

UniProtKB/Swiss-Prot genetic disease variations for Pyruvate Dehydrogenase E1-Alpha Deficiency:

70 (show all 20)
id Symbol AA change Variation ID SNP ID
1PDHA1p.Arg72CysVAR_004949rs863224148
2PDHA1p.His113AspVAR_004950
3PDHA1p.Gly162ArgVAR_004951rs866868610
4PDHA1p.Val167MetVAR_004952
5PDHA1p.Ala199ThrVAR_004953
6PDHA1p.Phe205LeuVAR_004954rs137853254
7PDHA1p.Met210ValVAR_004955rs794727843
8PDHA1p.Pro217LeuVAR_004956
9PDHA1p.Thr231AlaVAR_004957
10PDHA1p.Asp258AlaVAR_004958rs137853253
11PDHA1p.Arg263GlyVAR_004959rs28936081
12PDHA1p.Arg263GlnVAR_004960
13PDHA1p.His292LeuVAR_004961
14PDHA1p.Arg302CysVAR_004962rs137853252
15PDHA1p.Arg302HisVAR_004963
16PDHA1p.Arg378HisVAR_004966rs137853250
17PDHA1p.Arg10ProVAR_010238rs137853257
18PDHA1p.Tyr243AsnVAR_021053rs137853255
19PDHA1p.Arg288HisVAR_021055rs137853258
20PDHA1p.Asp315AsnVAR_021056rs28935187

Clinvar genetic disease variations for Pyruvate Dehydrogenase E1-Alpha Deficiency:

5 (show all 24)
id Gene Variation Type Significance SNP ID Assembly Location
1PDHA1NM_000284.3(PDHA1): c.1167_1170delCAGT (p.Ser390Lysfs)deletionPathogenicrs606231184GRCh38Chr X, 19359647: 19359650
2PDHA1NM_000284.3(PDHA1): c.934_940delAGTAAGA (p.Ser312Valfs)deletionPathogenicrs606231185GRCh38Chr X, 19358950: 19358956
3PDHA1NM_000284.3(PDHA1): c.1133G> A (p.Arg378His)SNVPathogenicrs137853250GRCh37Chr X, 19377731: 19377731
4PDHA1NM_000284.3(PDHA1): c.937_939delAAG (p.Lys313del)deletionPathogenicrs137853251GRCh37Chr X, 19377071: 19377073
5PDHA1NM_000284.3(PDHA1): c.1159_1160delAA (p.Lys387Valfs)deletionPathogenicrs606231186GRCh38Chr X, 19359639: 19359640
6PDHA1NM_000284.3(PDHA1): c.1073_1092del20 (p.Glu358Glyfs)deletionPathogenicrs606231187GRCh38Chr X, 19359553: 19359572
7PDHA1NM_000284.3(PDHA1)duplicationPathogenicrs606231188GRCh38Chr X, 19358913: 19358933
8PDHA1NM_000284.3(PDHA1): c.787C> G (p.Arg263Gly)SNVPathogenicrs137853259GRCh37Chr X, 19373831: 19373831
9PDHA1NM_000284.3(PDHA1): c.904C> T (p.Arg302Cys)SNVLikely pathogenic, Pathogenicrs137853252GRCh37Chr X, 19377038: 19377038
10PDHA1NM_000284.3(PDHA1): c.1142_1145dupATCA (p.Trp383Serfs)duplicationPathogenicrs606231189GRCh38Chr X, 19359622: 19359625
11PDHA1NM_000284.3(PDHA1): c.773A> C (p.Asp258Ala)SNVPathogenicrs137853253GRCh37Chr X, 19373817: 19373817
12PDHA1NM_000284.3(PDHA1): c.615C> G (p.Phe205Leu)SNVPathogenicrs137853254GRCh37Chr X, 19373478: 19373478
13PDHA1NM_000284.3(PDHA1): c.727T> A (p.Tyr243Asn)SNVPathogenicrs137853255GRCh37Chr X, 19373590: 19373590
14PDHA1NM_000284.3(PDHA1): c.943G> A (p.Asp315Asn)SNVPathogenicrs137853256GRCh37Chr X, 19377077: 19377077
15PDHA1NM_000284.3(PDHA1): c.844A> C (p.Met282Leu)SNVPathogenicrs2229137GRCh37Chr X, 19375782: 19375782
16PDHA1NM_000284.3(PDHA1): c.861_862insT (p.Arg288Serfs)insertionPathogenicrs606231190GRCh38Chr X, 19357681: 19357682
17PDHA1NM_000284.3(PDHA1): c.29G> C (p.Arg10Pro)SNVPathogenicrs137853257GRCh37Chr X, 19362184: 19362184
18PDHA1PDHA1, 13-BP INS, EX10insertionPathogenicChr na, -1: -1
19PDHA1NM_000284.3(PDHA1)duplicationPathogenicrs606231191GRCh38Chr X, 19359554: 19359589
20PDHA1NM_000284.3(PDHA1): c.863G> A (p.Arg288His)SNVPathogenicrs137853258GRCh37Chr X, 19375801: 19375801
21PDHA1NM_000284.3(PDHA1): c.*79_*90dupAGTCAATGAAATduplicationPathogenicrs606231192GRCh38Chr X, 19359732: 19359743
22PDHA1NM_000284.3(PDHA1): c.648A> C (p.Leu216Phe)SNVPathogenicrs121917898GRCh37Chr X, 19373511: 19373511
23PDHA1NM_000284.3(PDHA1): c.422G> A (p.Arg141Gln)SNVPathogenicrs794729213GRCh37Chr X, 19371203: 19371203
24PDHA1NM_000284.3(PDHA1): c.640T> C (p.Trp214Arg)SNVLikely pathogenicrs886042089GRCh37Chr X, 19373503: 19373503

Expression for genes affiliated with Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section
Search GEO for disease gene expression data for Pyruvate Dehydrogenase E1-Alpha Deficiency.

Pathways for genes affiliated with Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section

Pathways related to Pyruvate Dehydrogenase E1-Alpha Deficiency according to GeneCards Suite gene sharing:

(show all 13)
idSuper pathwaysScoreTop Affiliating Genes
19.5PDHA1, PDHB
29.5PDHA1, PDHB
39.5PDHA1, PDHB
4
Show member pathways
9.0PDHA1, PDHB, PDHX
5
Show member pathways
9.0PDHA1, PDHB, PDHX
6
Show member pathways
9.0PDHA1, PDHB, PDHX
7
Show member pathways
9.0PDHA1, PDHB, PDHX
8
Show member pathways
8.9PC, PDHA1, PDHB
9
Show member pathways
8.9PC, PDHA1, PDHB
10
Show member pathways
8.4PC, PDHA1, PDHB, PDHX
11
Show member pathways
8.2HIBCH, PDHA1, PDHB, PDHX
12
Show member pathways
8.1HIBCH, PC, PDHA1, PDHB
13
Show member pathways
7.5HIBCH, PC, PDHA1, PDHB, PDHX

GO Terms for genes affiliated with Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section

Cellular components related to Pyruvate Dehydrogenase E1-Alpha Deficiency according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1pyruvate dehydrogenase complexGO:00452549.0PDHA1, PDHB, PDHX
2mitochondrial matrixGO:00057598.3HIBCH, PC, PDHA1, PDHB, PDHX
3mitochondrionGO:00057397.7HIBCH, PC, PDHA1, PDHB, PDHX

Biological processes related to Pyruvate Dehydrogenase E1-Alpha Deficiency according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1acetyl-CoA biosynthetic process from pyruvateGO:000608610.1PDHA1, PDHB
2glucose metabolic processGO:000600610.0PDHA1, PDHB
3tricarboxylic acid cycleGO:00060999.5PDHA1, PDHB
4glyoxylate metabolic processGO:00464879.5PDHA1, PDHB, PDHX
5mitochondrial acetyl-CoA biosynthetic process from pyruvateGO:00617329.5PDHA1, PDHB, PDHX
6regulation of acetyl-CoA biosynthetic process from pyruvateGO:00105109.4PDHA1, PDHB, PDHX
7pyruvate metabolic processGO:00060908.8PC, PDHA1, PDHB, PDHX

Molecular functions related to Pyruvate Dehydrogenase E1-Alpha Deficiency according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1pyruvate dehydrogenase (acetyl-transferring) activityGO:00047399.7PDHA1, PDHB
2pyruvate dehydrogenase activityGO:00047389.5PDHA1, PDHB
3pyruvate dehydrogenase (NAD+) activityGO:00346048.9PDHA1, PDHB, PDHX

Sources for Pyruvate Dehydrogenase E1-Alpha Deficiency

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet